Category & trade
Primary
pharmaceutical-drugs · embed-ft 0.89
Tree path
Medical Health › Pharmaceutical Drugs
Group (tier-1)
Tech stack
CMS
Analytics
CDN
Framework
Consent/CMP
AI readiness
AI-Readiness score
40 / 100 · partial · see similar
AI training policy
allowed
Terms of Service
AI-bot protection
AI files
llms.txt ai.txt humans.txt robots.txt
Compliance (GEO / GDPR)
TLD
Overview
Title
DUPIXENT® (dupilumab) HCP Website
Description
DUPIXENT® (dupilumab) is a dual inhibitor of IL-4 and IL-13 signaling and is approved for 9 indications. The mechanism of dupilumab action has not been definitively established. Serious adverse reactions may occur. Please see Important Safety Information and full Prescribing Information on website.
Final URL
Language
en (html)
Scanned at
2026-07-27 02:50:42
Embed AI-status badge
Show this site's AI-access status with a free, live badge — it reflects AI-Accessible and updates automatically as the site changes.
Embed code (HTML)